| 1 |
35202638 | Dual targeting nanoparticles based on hyaluronic and folic acids as a promising delivery system of the encapsulated 4-Methylumbelliferone (4-MU) against invasiveness of lung cancer in vivo and in vitro. | 2022 May 1 |
1 |
| 2 |
33921242 | Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. | 2021 Apr 12 |
1 |
| 3 |
34628469 | Antitumor effect of 4MU on glioblastoma cells is mediated by senescence induction and CD44, RHAMM and p-ERK modulation. | 2021 Oct 9 |
2 |
| 4 |
31804840 | HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer. | 2020 Jan 6 |
1 |
| 5 |
32016803 | Inhibition of Hyaluronic Acid Synthesis Decreases Endometrial Cell Attachment, Migration, and Invasion. | 2020 Apr |
1 |
| 6 |
28972965 | Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets. | 2017 Nov 7 |
1 |
| 7 |
26005723 | Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. | 2015 Jul |
4 |
| 8 |
23228386 | Dietary supplement hymecromone and sorafenib: a novel combination for the control of renal cell carcinoma. | 2013 Jul |
1 |
| 9 |
23288481 | Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer. | 2013 Jun |
1 |